Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Benigni

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Lancet (London, England)|September 4, 1993
Endothelins in the control of cardiovascular and renal functionG Remuzzi, A Benigni
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1994
The role of eicosanoids in the pathogenesis of hemolytic uremic syndromeA Benigni, G Remuzzi
Kidney International|December 15, 2000
Repairing renal lesions: will VEGF be the builder?G Remuzzi, A Benigni
European Journal of Clinical Investigation|April 2, 2009
Endothelin receptor selectivity in chronic renal failureL Longaretti, A Benigni
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1998
Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases?A Benigni, G Remuzzi
Clinical and Experimental Pharmacology & Physiology|April 1, 1996
Endothelin is a key modulator of progressive renal injury: experimental data and novel therapeutic strategiesI Bruzzi, A Benigni
Springer Seminars in Immunopathology|January 1, 1994
Inflammation and glomerular injuryA Benigni, G Remuzzi
Mineral and Electrolyte Metabolism|January 1, 1995
Endothelin in the progressive renal disease of glomerulopathiesA Benigni, G Remuzzi
Current Gene Therapy|March 23, 2004
Gene therapy: how to target the kidney. Promises and pitfallsS Tomasoni, A Benigni
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 17, 1998
Mechanism of progression of renal disease: growth factors and related mechanismsA Benigni, G Remuzzi
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Lancet (London, England)|September 4, 1993
Endothelins in the control of cardiovascular and renal functionG Remuzzi, A Benigni
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1994
The role of eicosanoids in the pathogenesis of hemolytic uremic syndromeA Benigni, G Remuzzi
Kidney International|December 15, 2000
Repairing renal lesions: will VEGF be the builder?G Remuzzi, A Benigni
European Journal of Clinical Investigation|April 2, 2009
Endothelin receptor selectivity in chronic renal failureL Longaretti, A Benigni
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1998
Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases?A Benigni, G Remuzzi
Clinical and Experimental Pharmacology & Physiology|April 1, 1996
Endothelin is a key modulator of progressive renal injury: experimental data and novel therapeutic strategiesI Bruzzi, A Benigni
Springer Seminars in Immunopathology|January 1, 1994
Inflammation and glomerular injuryA Benigni, G Remuzzi
Mineral and Electrolyte Metabolism|January 1, 1995
Endothelin in the progressive renal disease of glomerulopathiesA Benigni, G Remuzzi
Current Gene Therapy|March 23, 2004
Gene therapy: how to target the kidney. Promises and pitfallsS Tomasoni, A Benigni
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 17, 1998
Mechanism of progression of renal disease: growth factors and related mechanismsA Benigni, G Remuzzi
Pageof 15